Free Trial
OTCMKTS:PVCT

Provectus Biopharmaceuticals (PVCT) Stock Price, News & Analysis

Provectus Biopharmaceuticals logo
$0.08 +0.00 (+2.27%)
As of 03:35 PM Eastern

About Provectus Biopharmaceuticals Stock (OTCMKTS:PVCT)

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.07
$0.10
52-Week Range
$0.04
$0.15
Volume
77,266 shs
Average Volume
199,304 shs
Market Capitalization
$32.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PVCT Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Provectus announces $3M seed financing round for VisiRose
Provectus announces the launch of VisiRose
See More Headlines

PVCT Stock Analysis - Frequently Asked Questions

Provectus Biopharmaceuticals' stock was trading at $0.1201 at the start of the year. Since then, PVCT stock has decreased by 36.1% and is now trading at $0.0767.

Shares of PVCT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provectus Biopharmaceuticals investors own include Vertex Energy (VTNR), Good Times Restaurants (GTIM), Merck & Co., Inc. (MRK), Oncolytics Biotech (ONC), American Superconductor (AMSC), Cannabis Science (CBIS) and (DARA) (DARA).

Company Calendar

Today
7/08/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PVCT
Previous Symbol
NYSEMKT:PVCT
CIK
315545
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.76 million
Net Margins
-815.81%
Pretax Margin
-823.71%

Debt

Sales & Book Value

Annual Sales
$620 thousand
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-7.67

Miscellaneous

Free Float
366,484,000
Market Cap
$32.24 million
Optionable
Not Optionable
Beta
0.75
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:PVCT) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners